Literature DB >> 21812323

Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.

Jeong Hoon Kim1, Sun Woo Jang, Sang Dug Han, Hyung Don Hwang, Han-Gon Choi.   

Abstract

To develop a novel ciclosporin A (CsA)-loaded nanosuspension causing less ocular irritation, a range of nanosuspensions was prepared with various polymers using a media milling method. The effects of polymer, milling time, milling speed and bead material on the particle size of the nanosuspension were investigated. Stability and irritation tests in rabbits' eyes were then performed comparing the nanosuspension with a commercial product. Of the nanosuspensions prepared with various polymers, that with PVA showed no creaming or sedimentation phenomena and gave the smallest particles of about 530 nm. The particle size decreased abruptly as the milling time increased to 2 h and then hardly decreased further. As the milling speed was increased, the particle size of CsA in the nanosuspension also increased. Nanosuspensions prepared with zirconia beads gave significantly finer particles than those with polystyrene beads. In particular, the CsA-loaded nanosuspension with a CsA/PVA/water weight ratio of 0.5/1/100 prepared using the top-down media milling method with zirconia beads of 300 microm diameter at 1000 rpm for 2 h gave a minimum particle size of about 530 nm. This nansuspension was physcally and chemically stable for at least two months. In the Draize test, both this nanosuspension and the commercial product gave very slight ocular irritation. However, in the Schirmer tear test, this nanosuspension caused less irritation to the rabbits' eyes compared to the commercial product. Thus, the CsA-loaded nanosuspension prepared with PVA and water using the top-down media milling method could be a promising candidate for causing less ocular irritation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812323

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

Review 1.  Nanocrystal for ocular drug delivery: hope or hype.

Authors:  Om Prakash Sharma; Viral Patel; Tejal Mehta
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 2.  Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors:  Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal:  Pharmaceutics       Date:  2018-02-27       Impact factor: 6.321

3.  Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity.

Authors:  Mohamed A Ibrahim; Gamal A Shazly; Fadilah S Aleanizy; Fulwah Y Alqahtani; Gehan M Elosaily
Journal:  Saudi Pharm J       Date:  2018-07-20       Impact factor: 4.330

4.  Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits.

Authors:  Lubna M Eldesouky; Riham M El-Moslemany; Alyaa A Ramadan; Mahmoud H Morsi; Nawal M Khalafallah
Journal:  Pharmaceutics       Date:  2021-03-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.